- Granted Orphan Drug Exclusivity through May 1, 2030 --Advanced commercial preparations on track; LUMRYZ product availability expected in early June -- Final approval supported by robust efficacy and safety data from
The global market for weight-loss drugs is expected to reach a staggering $150 billion by the early 2030s, a significant increase from the previous forecast of $100 billion. This surge is attributed to the growing availability of weight-loss medications.